With a list price of $22,600 when administered every six weeks, Keytruda is now the top-selling drug ... Gardasil has become ...

If a company shows a lot of potential, investors are often willing to pay a premium and take on some risk in exchange for ...

The Zacks Research Daily presents the best research output ... later in the decade. However, Merck beat second-quarter estimates for earnings and sales. Products like Keytruda and Gardasil have ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The company has previously reached settlement agreements with more than 20 other generics ... a big victory for Merck, given that Januvia remains its third best-selling product after cancer ...

a significant contribution from new products like Welireg and Vaxneuvance vaccine and the Animal Health segment can keep driving top-line growth. Merck is pinning hopes on PAH drug Winrevair to ...

At the highest dose tested, Vaxcyte’s shot elicited a stronger immune response against 18 of the 20 strains compared with ...

Over more than 20 years in the pharma industry ... and to direct R&D efforts where they can best help patients. To achieve this objective, in 2017, Merck launched a first-of-its-kind initiative ...

We recently compiled a list of the 10 Best Cancer Stocks To Buy Now. In this article, we are going to take a look at where Merck & Co ... fast with over 2,000 products being in the pipeline.

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

We recently compiled a list of the 10 Best Defensive Stocks According to Reddit. In this article, we will look at where Merck & Co., Inc. (NYSE ... We compiled an initial list of 20 stocks and then ...